Depomed - Diabetes Royalty Rights - Ownership and Business Overview

Medical ProductsCompany

Depomed - Diabetes Royalty Rights Ownership

Who owns Depomed - Diabetes Royalty Rights?

Depomed - Diabetes Royalty Rights is owned by PDL BioPharma. It was acquired on November 4, 2015.

Depomed - Diabetes Royalty Rights Business Overview

Where is Depomed - Diabetes Royalty Rights headquartered?

Depomed - Diabetes Royalty Rights is headquartered in United States.

What sector is Depomed - Diabetes Royalty Rights in?

Depomed - Diabetes Royalty Rights is a medical products company.

Medical Products M&A Summary in 2015

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2015. The largest medical products acquisition in 2015 was Sirona Dental Systems - which was acquired by Dentsply Sirona for $5.6B.

Join Mergr to view all 266 acquisitions of medical products companies in 2015, including 24 acquisitions by private equity firms, and 242 by strategics.

Depomed - Diabetes Royalty Rights


United States,

Depomed - Diabetes Royalty Rights is a provider of medical products.


 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Depomed - Diabetes Royalty Rights

Medical Products Companies , United States Companies